AMERICAN SOCIETY OF CYTOPATHOLOGY INC

EIN: 042255896 501(c)(3) Diseases & Disorders

WILMINGTON, DE

Total Revenue
$1,529,175
Total Expenses
$1,506,021
Total Assets
$2,202,371
Net Assets
$1,885,799
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1966
Legal Domicile
DE
Phone
3025436583
Tax Period
2023-07-01 to 2024-06-30

AMERICAN SOCIETY OF CYTOPATHOLOGY INC, founded in 1966, is a community nonprofit in the Diseases & Disorders sector that reported $1.5M in total revenue in fiscal year 2023. Revenue decreased 5% compared to the prior year.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $170,947
Program Service Revenue $1,128,098
Investment Income $230,130
Other Revenue $0
TOTAL REVENUE $1,529,175

Expense Breakdown

Grants Paid $76,026
Salaries & Benefits $576,502
Fundraising Expenses $60,587
Program Expenses $1,020,452
Other Expenses $853,493
TOTAL EXPENSES $1,506,021

Year-over-Year Comparison

2023 2022 Change
Revenue $1,529,175 $1,610,455 -0.1%
Expenses $1,506,021 $1,608,040 -0.1%
Net Income $23,154 $2,415 +8.6%
Key Indicators
✓ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
16
Independent Members
16
Employees
5
Volunteers
N/A

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
16
$0
Total Directors
1
$147,993
Key Employees
1
$147,993
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
ELIZABETH JENKINS EXECUTIVE DIRECTOR 40.00
Director Key Emp
$128,690 $19,303 $147,993
MOMIN T SIDDIQUI MD PRESIDENT 5.00
Officer
$0 $0 $0
KRISTEN ATKINS MD PRESIDENT ELECT 5.00
Officer
$0 $0 $0
AMY C CLAYTON MD SECRETARY-TREASURER 5.00
Officer
$0 $0 $0
CHRISTINE N BOOTH MD VICE-PRESIDENT 5.00
Officer
$0 $0 $0
SEAN A MCNAIR MPH CT EXECUTIVE BOARD MEMBER 5.00
Officer
$0 $0 $0
MICHELLE D REID MD EXECUTIVE BOARD MEMBER 5.00
Officer
$0 $0 $0
MICHAEL J THRALL MD EXECUTIVE BOARD MEMBER 5.00
Officer
$0 $0 $0
OSCAR LIN MD PhD EXECUTIVE BOARD MEMBER 5.00
Officer
$0 $0 $0
DEBORAH J CHUTE MD EXECUTIVE BOARD MEMBER 5.00
Officer
$0 $0 $0
SUSAN A ALPERSTEIN CT EXECUTIVE BOARD MEMBER 5.00
Officer
$0 $0 $0
CATHERINE E BAMMERT PHD CT EXECUTIVE BOARD MEMBER 5.00
Officer
$0 $0 $0
FANG FAN MD PHD EXECUTIVE BOARD MEMBER 5.00
Officer
$0 $0 $0
JACQUELINE M CUDA BS SCTASCP EXECUTIVE BOARD MEMBER 5.00
Officer
$0 $0 $0
VIVIAN L WEISS MD PHD EXECUTIVE BOARD MEMBER 5.00
Officer
$0 $0 $0
SINCHITA ROY-CHOWDHURI PHD EXECUTIVE BOARD MEMBER 5.00
Officer
$0 $0 $0
CHRISTOPHER J VANDENBUSSCHE MD PHD EXECUTIVE BOARD MEMBER 5.00
Officer
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 No data No data No data No data
2024 $1,529,175 $1,506,021 $2,202,371 $23,154
2023 $1,610,455 $1,608,040 $2,070,368 $2,415
2022 $1,320,558 $1,347,815 $2,069,799 $-27,257
2021 $1,451,735 $1,011,758 $2,644,204 $439,977
Explore More Nonprofits
→Top 100 Nonprofits in Delaware →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare AMERICAN SOCIETY OF CYTOPATHOLOGY INC with other nonprofits in Delaware and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.